1 – 4 of 4
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study
(
- Contribution to journal › Article
- 2023
-
Mark
Risk factors for the development of opioid use disorder after first opioid prescription : a Swedish national study
(
- Contribution to journal › Article
- 2018
-
Mark
Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice
(
- Contribution to journal › Article
- 2017
-
Mark
Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade : An Open-Label Phase 1 Study
(
- Contribution to journal › Article